SK bioscience : Interim Report on Business Performance (Fair Disclosure)

Interim Report on Business Performance (Fair Disclosure)

※ The following are interim figures, and may be different from final data.
1. Details of business performance	in KRW mn, %
Category	Current period	Previous period	Changes over previous period (%)	Same period of last year	Changes over same period of last year (%)
('22.2Q)	('22.1Q )	('21.2Q)
Sales	Current	138,281	87,091	58.8	144,604	-4.4
Cumulative	225,372	87,091	-	257,314	-12.4
Operating income	Current	61,190	23,752	157.6	66,155	-7.5
Cumulative	84,942	23,752	-	119,870	-29.1
Net income from continuing operation before income tax	Current	55,343	32,757	69.0	67,892	-18.5
Cumulative	88,100	32,757	-	122,934	-28.3
Net income	Current	46,126	27,806	65.9	52,812	-12.7
Cumulative	73,932	27,806	-	94,736	-22.0
-	-	-	-	-	-
2. Details of information released	Information provider	IR Team
Information recipients	Domestic and foreign investors, media, etc.
Date & time of information released	July 28 (THU) 4:00 pm
Title and place of event held	Investor Relations Event (Conference call)
3. Contact points (department/phone number)	IR Team / 02-2008-2136
4. Other matters to be factored into investment decisions
- The performance results above are interim results on a separate basis prepared in accordance with Korean International Financial Reporting Standards (K-IFRS). - The performance results above are subject to change depending on the external auditor's accounting review.
※ Related disclosure	-